Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-01-20 Transaction in Own Shar…
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 5th Interim Report
Transaction in Own Shares Classification · 100% confidence The document explicitly details the acquisition of shares by Alzchem Group AG as part of a previously announced share buyback programme. It provides specific dates, the number of shares acquired, and the weighted average price, which is a direct report of a transaction in the company's own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). Although it mentions an 'Interim Report' in the title, the body content is solely focused on the buyback disclosure required under EU regulations, not the financial performance of the interim period itself. The key phrase is 'Share Buyback' and the tabular data confirms the transaction details.
2025-01-20 English
Alzchem Group AG: Utilization of surplus hydrogen: Alzchem replaces natural gas and saves significantly reduces CO2 emissions
Environmental & Social Information Classification · 99% confidence The document is a press release dated January 17, 2025, disseminated via EQS News. The content details an operational update regarding Alzchem Group AG utilizing surplus hydrogen to replace natural gas, leading to CO2 emission reductions and cost savings. This is a general corporate announcement focusing on environmental and operational improvements, not a formal financial filing like a 10-K, IR, or ER. It mentions environmental performance ('climate roadmap', 'CO2 reduction') and is distributed as 'EQS-Media'. While it touches upon ESG factors, it is primarily an operational news release. Given the options, it most closely aligns with a general regulatory announcement or news release that doesn't fit a specific financial report category. However, since it explicitly discusses environmental performance and sustainability goals, the 'Environmental & Social Information' (SR) category is a strong candidate, as ESG reporting is often released via press releases. Alternatively, as a general news release distributed via EQS, 'RNS' (Regulatory Filings) is the fallback. Since the core topic is the environmental impact and sustainability measure (saving 1,000 tonnes of CO2), SR is more specific than RNS. I will classify it as SR, as it is a specific announcement related to the company's environmental performance metrics.
2025-01-18 English
Alzchem Group AG: Utilization of surplus hydrogen: Alzchem replaces natural gas and saves significantly reduces CO2 emissions
Environmental & Social Information Classification · 99% confidence The document is a press release dated January 17, 2025, disseminated via EQS News. The content details an operational update regarding Alzchem Group AG utilizing surplus hydrogen to replace natural gas, leading to CO2 emission reductions and cost savings. This is a general corporate announcement focusing on environmental and operational improvements, not a formal financial filing like a 10-K, IR, or ER. It mentions environmental performance ('climate roadmap', 'CO2 reduction') and is distributed as 'EQS-Media'. While it touches upon ESG factors, it is primarily an operational news release. Given the options, it most closely aligns with a general regulatory announcement or news release that doesn't fit a specific financial report category. However, since it explicitly discusses environmental performance and sustainability goals, the 'Environmental & Social Information' (SR) category is a strong candidate, as ESG reporting is often released via press releases. Alternatively, as a general news release distributed via EQS, 'RNS' (Regulatory Filings) is the fallback. Since the core topic is the environmental impact and sustainability measure (saving 1,000 tonnes of CO2), SR is more specific than RNS. I will classify it as SR, as it is a specific announcement related to the company's environmental performance metrics.
2025-01-17 English
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 4th Interim Report
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure dated January 7, 2025, titled 'Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 – 4th Interim Report'. The content explicitly details the number of shares acquired during a specific period (December 30, 2024, to January 3, 2025) as part of a share buyback programme. This directly relates to the company purchasing its own stock. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases. Although it mentions an 'Interim Report' in the title, the body is exclusively about the buyback transaction details, not a comprehensive financial report (which would be IR or 10-K).
2025-01-08 English
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 4th Interim Report
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure dated January 7, 2025, titled 'Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 – 4th Interim Report'. The content explicitly details the number of shares acquired during a specific period (December 30, 2024, to January 3, 2025) as part of a share buyback programme. This directly relates to the company purchasing its own stock. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases. Although it mentions an 'Interim Report' in the title, the body is exclusively about the buyback transaction details, not a comprehensive financial report (which would be IR or 10-K).
2025-01-07 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') crossing specific thresholds (e.g., 3% and below). It references German securities law (WpHG) and details the acquisition/disposal of shares with voting rights by a specific legal entity. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2024-12-31 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.